BOBO DONALD E JR 4

What Happened Donald E. BoBo Jr., CVP, Strategy/Corporate Development at Edwards Lifesciences, sold a total of 17,968 shares in open-market transactions on 2026-05-15. The filing reports 9,968 shares sold at a weighted average price of $82.07 (proceeds $818,106) and 8,000 shares sold at $81.82 (proceeds $654,573), for aggregate proceeds of about $1,472,679. These were sales (dispositions), not purchases or option exercises.

Key Details

• Transaction dates: 2026-05-15 (reported on Form 4 filed 2026-05-18).
• Prices reported: $82.07 (first lot, weighted average) and $81.82 (second lot). Footnote F1 says the first reported sale was executed in multiple trades at prices ranging $81.975–$82.260; the $82.07 is the weighted average.
• Shares sold: 9,968 and 8,000 (total 17,968). Total proceeds ≈ $1.47M.
• Shares owned after transaction: Not disclosed in the supplied filing excerpt.
• Filing timeliness: Reported on 2026-05-18 for transactions on 2026-05-15; the filing appears timely based on the supplied dates.
• Remarks/footnote: The Form 4 notes it reflects changes in beneficial ownership only and does not list other issuer securities the reporting person may own.

Context

• These were routine open-market sales by a senior corporate development officer, not an option exercise or gift. Sales alone do not necessarily indicate the insider’s view of the company; purchases are generally more informative for signaling confidence.
• No 10b5-1 plan or other trading-plan language is indicated in the provided excerpt.